The HAS Board is responsible for providing strategic direction, programming and implementation of its legislative-assigned scope of action and function. As the decision-making body of HAS, it is responsible for maintaining high standards and impartiality of its activities and results. The Board deliberates on opinions, recommendations and decisions regarding certification, and on the accreditation procedure for healthcare organisations, as well as on the annual budget and accounts, internal regulations (Board, committees, departments), accounting and financial regulations, and loans and investment of reserves.
The Board is comprised of seven members, appointed by decree of the President of the French Republic based on various government proposals (President of the French Republic, health Minister, President of the French Senate, President of the French National Assembly, President of the French Economic, Social and Environmental Council). The term runs for 6 years and is renewed once, with half of the Board renewed every 3 years.
Members of the Board
Dominique Le Guludec, President
Anne-Marie Armanteras-de Saxcé,
With the support of their respective scientific and technical division, the 8 specialist committees are responsible for examining the dossiers that fall within their area of expertise. Each specialist committee is chaired by a Board member and operates according to its own internal regulations.
Best practices, appropriate use and health care strategies
Dr Cédric Grouchka
Accreditation of healthcare organisations
Anne-Marie Armanteras-de Saxcé
Evaluation of medicinal products
Pr Christian Thuillez
Economic and public health evaluation
Evaluation of medical devices and health technologies
|Expertise on vaccines and vaccination||Technical Committee on Vaccinations|
Pr Elisabeth Bouvet
Improvement of physician practice and relevance, physician accreditation program, continuing professional development, patient safety
|Evaluation of social care services and best practices||Anne-Marie Armanteras-de Saxcé|